Company Analysis

Axogen, Inc. (AXGN)

Nasdaq: AXGN · Electromedical & Electrotherapeutic Apparatus · Alachua, FL · filing with the SEC since 1995
Grade6.1
◀ Past 6.4● Present 6.6▶ Future 5.1
1 est.

Who runs Axogen, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Dale Michael D
Chief Executive Officer. First filing Aug 2024, latest Feb 27, 2026, 2 filings in all.
Officers reporting now
6
of 13 people with a filing in the last fifteen months
Directors reporting now
7
36 people on the record since 2010
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Began Marc AEVP & General CounselMar 2023Aug 12, 20263 · $3.9M
Hartley Lindsey MarieCFOMay 2025May 8, 20265 · $900,000
Kemp JensChief Marketing OfficerJan 2024May 8, 20262 · $400,000
Quackenbush DorisSales VPMay 2026May 8, 20261 · $200,000
Devinney Erick WayneChief Innovation OfficerJan 2014Mar 18, 20262 · $800,000
Dale Michael DChief Executive OfficerAug 2024Feb 27, 20262 · $2.7M
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Tyndall Joseph A.directorDec 2022Sep 4, 20263 · $1.0M
Wendell Amy McbridedirectorOct 2016Aug 12, 20265 · $2.0M
Weiler Kathy JohnsondirectorJan 2024Aug 11, 20265 · $2.7M
Burke William P. Mr.directorJul 2022Jun 26, 202613 · $2.8M
Johnson JohndirectorJul 2021Jun 26, 20265 · $1.9M
Levine Alan MdirectorMay 2019Jun 26, 2026none
Thomas PauldirectorSep 2020Jun 26, 20261 · $600,000
Earlier names on the record28, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton AXGN · research, not advice